tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

PTN Stock Latest News

Palatin files to sell 17.32M shares of common stock, warrants
The FlyPalatin files to sell 17.32M shares of common stock, warrants
6d ago
PTN
Palatin says BMT-801 Phase 2 obesity study met primary endpoint
PremiumThe Fly
Palatin says BMT-801 Phase 2 obesity study met primary endpoint
7d ago
PTN
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
9d ago
PTN
SNY
Palatin reports ‘positive’ results from Phase 2 study of PL8177
PremiumThe Fly
Palatin reports ‘positive’ results from Phase 2 study of PL8177
10d ago
PTN
Palatin: FDA grants orphan drug designation to PL7737
PremiumThe Fly
Palatin: FDA grants orphan drug designation to PL7737
12d ago
PTN
Palatin Technologies Reports Q2 2025 Financial Results
PremiumCompany AnnouncementsPalatin Technologies Reports Q2 2025 Financial Results
2M ago
PTN
Palatin’s Earnings Call: Mixed Results and Strategic Moves
Premium
Company Announcements
Palatin’s Earnings Call: Mixed Results and Strategic Moves
2M ago
PTN
Palatin price target lowered to $7 from $17 at H.C. Wainwright
Premium
The Fly
Palatin price target lowered to $7 from $17 at H.C. Wainwright
2M ago
PTN
Palatin reports Q2 EPS (12c) vs. (56c) last year
PremiumThe Fly
Palatin reports Q2 EPS (12c) vs. (56c) last year
2M ago
PTN
Palatin to sell 4.69M shares at $1.00 in registered direct offering
PremiumThe Fly
Palatin to sell 4.69M shares at $1.00 in registered direct offering
2M ago
PTN
Palatin reports positive Phase 2b results in diabetic nephropathy
PremiumThe Fly
Palatin reports positive Phase 2b results in diabetic nephropathy
4M ago
PTN
Palatin completes patient enrollment in Phase 2 study of PL8177
PremiumThe Fly
Palatin completes patient enrollment in Phase 2 study of PL8177
4M ago
PTN
Palatin Technologies Shifts Focus to Obesity Treatments
PremiumCompany AnnouncementsPalatin Technologies Shifts Focus to Obesity Treatments
5M ago
PTN
Palatin to report data from MC4R selective PL7737 obesity program
Premium
The Fly
Palatin to report data from MC4R selective PL7737 obesity program
5M ago
PTN
Palatin completes enrollment in Phase 2 study of bremelanotide in obesity
Premium
The Fly
Palatin completes enrollment in Phase 2 study of bremelanotide in obesity
5M ago
PTN
Palatin’s melanocortin agonists shows efficacy in inflammatory diseases
PremiumThe Fly
Palatin’s melanocortin agonists shows efficacy in inflammatory diseases
5M ago
PTN
Palatin receives notice of non-compliance from NYSE American
PremiumThe Fly
Palatin receives notice of non-compliance from NYSE American
6M ago
PTN
Palatin reports Q4 EPS (51c) vs (84c) last year
PremiumThe Fly
Palatin reports Q4 EPS (51c) vs (84c) last year
6M ago
PTN
PTN Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
PTN Upcoming Earnings Report: What to Expect?
7M ago
PTN
Palatin provides update on its clinical programs
PremiumThe FlyPalatin provides update on its clinical programs
7M ago
PTN
Palatin: FDA confirms acceptability of Phase 3 pivotal clinical trials for PL964
Premium
The Fly
Palatin: FDA confirms acceptability of Phase 3 pivotal clinical trials for PL964
7M ago
PTN
Palatin doses first patient in Phase 2 study of bremelanotide in obesity
Premium
The Fly
Palatin doses first patient in Phase 2 study of bremelanotide in obesity
8M ago
PTN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >